No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
10 Levered Big-caps That May Face Higher Refinancing Expenses
Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $62
Bernstein Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
Medicare Drug Prices Nearly Double, Surpassing Inflation: AARP
Bristol-Myers Squibb Hits 4-week Low